Key result
Blood flow restriction shows promise for mitigating quadriceps weakness after ACL reconstruction despite heterogeneous data.
Why the study?
Patients recovering from ACLR experience pain and activity restrictions leading to quadriceps muscle atrophy, while literature on blood flow restriction therapy remains heterogeneous and unstandardized.
Does blood flow restriction therapy improve quadriceps strength and return to sport in patients recovering from anterior cruciate ligament reconstruction?
Does blood flow restriction therapy improve quadriceps strength and return to sport in patients recovering from anterior cruciate ligament reconstruction?
Blood flow restriction therapy shows promise for mitigating quadriceps weakness after ACLR, but current literature is heterogeneous and lacks standardized protocols.
May support BFR for quadriceps weakness post-ACLR; leaves open standardization and efficacy confirmation in RCTs.
Anterior cruciate ligament reconstruction (ACLR) rehabilitation necessitates restoration of quadriceps strength to minimize reinjury and optimize return to sport (RTS). Patients recovering from ACLR are limited by pain and activity restrictions, resulting in quadriceps muscle atrophy. Blood flow restriction (BFR) therapy involves performing exercises while a specialized blood pressure cuff is applied to the proximal aspect of the operative extremity and inflated to 40% to 90% of the arterial occlusion pressure, as determined using Doppler ultrasonography. BFR is theorized to induce an anaerobic environment and metabolic stress during exercise, promoting muscle hypertrophy and strength gains. Although the physiological mechanism has not been fully elucidated, it is theorized that BFR combined with low-load resistance training could yield muscle adaptations comparable to those of high-load resistance training. For ACLR patients with pain and restrictions precluding high-intensity strength training, incorporation of BFR into postoperative rehabilitation protocols could help mitigate quadriceps weakness and promote RTS. Randomized controlled trials report a prolonged, dose-dependent relation between BFR use and quadriceps and hamstring strength gains, improved bone and muscle mass, and earlier RTS, whereas other studies report no significant difference in quadriceps size, strength, or patient satisfaction compared with controls. Furthermore, although generally considered safe, there are rare reports of associated adverse events such as rhabdomyolysis, and BFR should be avoided in patients with a history of thromboembolic disease or peripheral vasculopathy. The literature examining BFR after ACLR is heterogeneous; lacks standardization; and contains broad variation in reported cuff pressures, as well as timing and duration of BFR use, among protocols. Although the use of BFR after ACLR shows promise, further study is necessary to elucidate the efficacy, safety, and optimal protocols.
No takes yet. Share an insight, caveat, or question.
Johns et al. (2024) conducted a review in Anterior cruciate ligament reconstruction (ACLR). Blood flow restriction (BFR) therapy vs. Controls was evaluated. Blood flow restriction therapy after ACL reconstruction shows promise for mitigating quadriceps weakness, though current literature is heterogeneous and lacks standardization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: